Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

The disulfide isomerase ERp57 is required for fibrin deposition in vivo.

Zhou J, Wu Y, Wang L, Rauova L, Hayes VM, Poncz M, Essex DW.

J Thromb Haemost. 2014 Nov;12(11):1890-7. doi: 10.1111/jth.12709. Epub 2014 Sep 26.

PMID:
25156521
2.

T2 magnetic resonance: a diagnostic platform for studying integrated hemostasis in whole blood--proof of concept.

Skewis LR, Lebedeva T, Papkov V, Thayer EC, Massefski W, Cuker A, Nagaswami C, Litvinov RI, Kowalska MA, Rauova L, Poncz M, Weisel JW, Lowery TJ, Cines DB.

Clin Chem. 2014 Sep;60(9):1174-82. doi: 10.1373/clinchem.2014.223735. Epub 2014 Jun 23.

PMID:
24958814
3.

Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery.

Cuker A, Rauova L, Bolgiano D, Matthai WH Jr, Poncz M, Konkle BA.

Thromb Haemost. 2014 Jun;111(6):1191-3. doi: 10.1160/TH13-12-1012. Epub 2014 Jan 30. No abstract available.

PMID:
24477578
4.

Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin.

Cines DB, Lebedeva T, Nagaswami C, Hayes V, Massefski W, Litvinov RI, Rauova L, Lowery TJ, Weisel JW.

Blood. 2014 Mar 6;123(10):1596-603. doi: 10.1182/blood-2013-08-523860. Epub 2013 Dec 13.

5.

Bad (or good) things come in small packages.

Rauova L, Cines DB.

Blood. 2013 Nov 28;122(23):3707-8. doi: 10.1182/blood-2013-09-522482. No abstract available.

6.

Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.

Litvinov RI, Yarovoi SV, Rauova L, Barsegov V, Sachais BS, Rux AH, Hinds JL, Arepally GM, Cines DB, Weisel JW.

J Biol Chem. 2013 Nov 15;288(46):33060-70. doi: 10.1074/jbc.M113.481598. Epub 2013 Oct 4.

7.

Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.

Zhi H, Rauova L, Hayes V, Gao C, Boylan B, Newman DK, McKenzie SE, Cooley BC, Poncz M, Newman PJ.

Blood. 2013 Mar 7;121(10):1858-67. doi: 10.1182/blood-2012-07-443325. Epub 2012 Dec 20.

8.

Diminished adhesion and activation of platelets and neutrophils with CD47 functionalized blood contacting surfaces.

Finley MJ, Rauova L, Alferiev IS, Weisel JW, Levy RJ, Stachelek SJ.

Biomaterials. 2012 Aug;33(24):5803-11. doi: 10.1016/j.biomaterials.2012.04.051. Epub 2012 May 20.

9.

Dynamic antibody-binding properties in the pathogenesis of HIT.

Sachais BS, Litvinov RI, Yarovoi SV, Rauova L, Hinds JL, Rux AH, Arepally GM, Poncz M, Cuker A, Weisel JW, Cines DB.

Blood. 2012 Aug 2;120(5):1137-42. doi: 10.1182/blood-2012-01-407262. Epub 2012 May 10.

10.

Platelet factor 4 platelet levels are inversely correlated with steady-state platelet counts and with platelet transfusion needs in pediatric leukemia patients.

Lambert MP, Reznikov A, Grubbs A, Nguyen Y, Xiao L, Aplenc R, Rauova L, Poncz M.

J Thromb Haemost. 2012 Jul;10(7):1442-6. doi: 10.1111/j.1538-7836.2012.04767.x. No abstract available.

11.

"Radical" model of thrombosis.

Rauova L.

Blood. 2012 Feb 23;119(8):1798-9. doi: 10.1182/blood-2011-12-394569.

12.

Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT.

Kowalska MA, Krishnaswamy S, Rauova L, Zhai L, Hayes V, Amirikian K, Esko JD, Bougie DW, Aster RH, Cines DB, Poncz M.

Blood. 2011 Sep 8;118(10):2882-8. doi: 10.1182/blood-2011-02-335208. Epub 2011 Jul 19.

13.

Infusion of mature megakaryocytes into mice yields functional platelets.

Fuentes R, Wang Y, Hirsch J, Wang C, Rauova L, Worthen GS, Kowalska MA, Poncz M.

J Clin Invest. 2010 Nov;120(11):3917-22. doi: 10.1172/JCI43326. Epub 2010 Oct 25.

14.

Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia.

Rauova L, Hirsch JD, Greene TK, Zhai L, Hayes VM, Kowalska MA, Cines DB, Poncz M.

Blood. 2010 Dec 2;116(23):5021-31. doi: 10.1182/blood-2010-03-276964. Epub 2010 Aug 19.

15.

Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis.

Kowalska MA, Rauova L, Poncz M.

Thromb Res. 2010 Apr;125(4):292-6. doi: 10.1016/j.thromres.2009.11.023. Epub 2009 Dec 9. Review.

PMID:
20004006
16.

Platelet and monocyte antigenic complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT).

Rauova L, Arepally G, McKenzie SE, Konkle BA, Cines DB, Poncz M.

J Thromb Haemost. 2009 Jul;7 Suppl 1:249-52. doi: 10.1111/j.1538-7836.2009.03373.x. Review.

17.

Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors.

Gewirtz J, Thornton MA, Rauova L, Poncz M.

J Thromb Haemost. 2008 Jul;6(7):1160-6. doi: 10.1111/j.1538-7836.2008.02992.x. Epub 2008 Jul 1.

PMID:
18433455
18.

Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice.

Woulfe DS, Lilliendahl JK, August S, Rauova L, Kowalska MA, Abrink M, Pejler G, White JG, Schick BP.

Blood. 2008 Apr 1;111(7):3458-67. Epub 2007 Dec 19.

19.

Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications.

Lambert MP, Rauova L, Bailey M, Sola-Visner MC, Kowalska MA, Poncz M.

Blood. 2007 Aug 15;110(4):1153-60. Epub 2007 May 10.

20.

Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.

Cines DB, Rauova L, Arepally G, Reilly MP, McKenzie SE, Sachais BS, Poncz M.

J Clin Apher. 2007 Feb;22(1):31-6. Review.

PMID:
17285619
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk